Therapeutic effect of local hyperthermia treatment combined with anti-CD200 immunotherapy in EMT6 breast cancer

Breast cancer is the leading cancer-causing death in women worldwide. Conventional cancer treatments have different therapeutic effects and commonly associated with side effects. Combinatorial therapies are typically used to overcome such limitation and reduce the likelihood of cancer recurrence. Hy...

Full description

Saved in:
Bibliographic Details
Main Author: Wan Mohd. Zawawi, Wan Fatin Amira
Format: Thesis
Language:English
Published: 2021
Subjects:
Online Access:http://eprints.utm.my/id/eprint/102247/1/WanFatinAmiraPFS2021.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-utm-ep.102247
record_format uketd_dc
spelling my-utm-ep.1022472023-08-17T00:22:06Z Therapeutic effect of local hyperthermia treatment combined with anti-CD200 immunotherapy in EMT6 breast cancer 2021 Wan Mohd. Zawawi, Wan Fatin Amira Q Science (General) Breast cancer is the leading cancer-causing death in women worldwide. Conventional cancer treatments have different therapeutic effects and commonly associated with side effects. Combinatorial therapies are typically used to overcome such limitation and reduce the likelihood of cancer recurrence. Hyperthermia (HT) is a less invasive cancer treatment ideal to treat superficial tumour and has shown promising outcomes in combination with the established immunotherapy. In EMT6 breast tumour, an elevated expression of CD200 has been associated with cancer progression. It was reported that the blocking of CD200/CD200R signalling resulted in an enhanced anti-tumour response. In light of this, the present study aimed to investigate the therapeutic effects of local HT in combination with anti-CD200 blockade therapy. Local HT protocol was established prior to the application of combined treatment. Breast tumours were induced by inoculating EMT6 cells subcutaneously at the right flank of Balb/c mice. On day seven post-inoculation, tumours were subjected to local HT treatment by near infrared radiation for three days. Tumour progression and mice survival were monitored and the influence on the immune response was evaluated. Results demonstrated that HT treatment reduced tumour progression and increased the median survival of tumour-bearing mice. Immunohistochemical analysis revealed a large area of necrotized tumour and there was an increase of Hsp70 expression observed around the treated tumour. This observation was accompanied with a significant reduction of proliferating cells when compared to the untreated tumour. Flow cytometry analysis of the lymph node showed an increase of dendritic cells activation and infiltration in treated mice. A higher level of IFN-γ, a pro-inflammatory cytokine but lower IL-10, an anti-inflammatory cytokine, were detected in blood of treated mice, as compared to untreated mice. In another experiment, mice were intraperitoneally injected with anti-CD200 antibody for blockade therapy in addition to HT. Following combined treatment, it was demonstrated that tumour progression was further delayed and the mice survival were greatly improved. In addition, an increase in the number of activated CD8 T cells were observed in the draining lymph nodes of the mice, along with infiltration of T cells, NK cells and B cells into the tumour. In contrast, tumour-infiltrated regulatory T cells and myeloid-derived suppressor cells were largely diminished from the tumour. Taken together, the present findings reveal the potential of combining local HT and anti-CD200 blockade in improving immunological response against breast tumour. 2021 Thesis http://eprints.utm.my/id/eprint/102247/ http://eprints.utm.my/id/eprint/102247/1/WanFatinAmiraPFS2021.pdf application/pdf en public http://dms.library.utm.my:8080/vital/access/manager/Repository/vital:147693 phd doctoral Universiti Teknologi Malaysia, Faculty of Science Faculty of Science
institution Universiti Teknologi Malaysia
collection UTM Institutional Repository
language English
topic Q Science (General)
spellingShingle Q Science (General)
Wan Mohd. Zawawi, Wan Fatin Amira
Therapeutic effect of local hyperthermia treatment combined with anti-CD200 immunotherapy in EMT6 breast cancer
description Breast cancer is the leading cancer-causing death in women worldwide. Conventional cancer treatments have different therapeutic effects and commonly associated with side effects. Combinatorial therapies are typically used to overcome such limitation and reduce the likelihood of cancer recurrence. Hyperthermia (HT) is a less invasive cancer treatment ideal to treat superficial tumour and has shown promising outcomes in combination with the established immunotherapy. In EMT6 breast tumour, an elevated expression of CD200 has been associated with cancer progression. It was reported that the blocking of CD200/CD200R signalling resulted in an enhanced anti-tumour response. In light of this, the present study aimed to investigate the therapeutic effects of local HT in combination with anti-CD200 blockade therapy. Local HT protocol was established prior to the application of combined treatment. Breast tumours were induced by inoculating EMT6 cells subcutaneously at the right flank of Balb/c mice. On day seven post-inoculation, tumours were subjected to local HT treatment by near infrared radiation for three days. Tumour progression and mice survival were monitored and the influence on the immune response was evaluated. Results demonstrated that HT treatment reduced tumour progression and increased the median survival of tumour-bearing mice. Immunohistochemical analysis revealed a large area of necrotized tumour and there was an increase of Hsp70 expression observed around the treated tumour. This observation was accompanied with a significant reduction of proliferating cells when compared to the untreated tumour. Flow cytometry analysis of the lymph node showed an increase of dendritic cells activation and infiltration in treated mice. A higher level of IFN-γ, a pro-inflammatory cytokine but lower IL-10, an anti-inflammatory cytokine, were detected in blood of treated mice, as compared to untreated mice. In another experiment, mice were intraperitoneally injected with anti-CD200 antibody for blockade therapy in addition to HT. Following combined treatment, it was demonstrated that tumour progression was further delayed and the mice survival were greatly improved. In addition, an increase in the number of activated CD8 T cells were observed in the draining lymph nodes of the mice, along with infiltration of T cells, NK cells and B cells into the tumour. In contrast, tumour-infiltrated regulatory T cells and myeloid-derived suppressor cells were largely diminished from the tumour. Taken together, the present findings reveal the potential of combining local HT and anti-CD200 blockade in improving immunological response against breast tumour.
format Thesis
qualification_name Doctor of Philosophy (PhD.)
qualification_level Doctorate
author Wan Mohd. Zawawi, Wan Fatin Amira
author_facet Wan Mohd. Zawawi, Wan Fatin Amira
author_sort Wan Mohd. Zawawi, Wan Fatin Amira
title Therapeutic effect of local hyperthermia treatment combined with anti-CD200 immunotherapy in EMT6 breast cancer
title_short Therapeutic effect of local hyperthermia treatment combined with anti-CD200 immunotherapy in EMT6 breast cancer
title_full Therapeutic effect of local hyperthermia treatment combined with anti-CD200 immunotherapy in EMT6 breast cancer
title_fullStr Therapeutic effect of local hyperthermia treatment combined with anti-CD200 immunotherapy in EMT6 breast cancer
title_full_unstemmed Therapeutic effect of local hyperthermia treatment combined with anti-CD200 immunotherapy in EMT6 breast cancer
title_sort therapeutic effect of local hyperthermia treatment combined with anti-cd200 immunotherapy in emt6 breast cancer
granting_institution Universiti Teknologi Malaysia, Faculty of Science
granting_department Faculty of Science
publishDate 2021
url http://eprints.utm.my/id/eprint/102247/1/WanFatinAmiraPFS2021.pdf
_version_ 1776100878345830400